View Profile

Koustav sarkar

Research Assistant Professor, Department of Biotechnology/ Engineering and Technology · SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India

https://researchid.co/ksarkar2022
@srmist.edu.in
94Scopus Publications
2193Google Scholar Citations
26Google Scholar h-index
55Google Scholar i10-index

Research Interests

My research focuses on explicating the molecular underpinnings of immune dysregulation and cancer immunotherapy. The broad components of my research interests are: 1. Immune dysregulation 2. Cancer immunotherapy

Biography

PROFESSIONAL CAREER: August, 2002 – Present Research Assistant Professor (SRM Research Institute, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu – 603203, India) [April 01, 2016 – Present] Post-Doctoral Research Scholar (University of Iowa Children’s Hospital, Iowa City, IA 52246, USA) [June 30, 2013 – March 25, 2016] Post-Doctoral Associate (Children’s Hospital of Pittsburgh, Pittsburgh, PA 15213, USA) [Sept 15, 2011 – June29, 2013] Post-Doctoral Research Fellow (Massachusetts General Hospital, Harvard University, Boston, MA 02114, USA) [Feb 02, 2009 - Sept 14, 2011] Senior Research Fellow (Indian Council of Medical Research) [Dec 1, 2005 - Jan 30, 2009] Junior Research Fellow (Department of Science and Technology, Govt. of India) [Mar 01, 2003 - Jul 24, 2005] Project Fellow (University Grants Commission, India) [Aug 14, 2002 - Feb 28, 2003] Major Field of research: Immunology Field of specialization: Cancer Immunology & Immunotherapy and Epigenetics

Education

PhD from Jadavpur University/Chittaranjan National Cancer Institute, Kolkata, West Bengal, India M,Sc. from Banaras Hindu University, Varanasi, Uttar Pradesh, India B.Sc. from University of Calcutta, Kolkata, West Bengal, India

Recent Scopus Publications

  1. STAT4 mediated modulation of T–B cell interactions profiling: enhances antitumor immunity in non-small cell lung cancer (NSCLC)
    Molecular Biology Reports, 2026
  2. Facilitation of STK19 in transcription coupled nuclear excision repair (TC-NER): Mechanisms, interactions, and genome stability
    Human Gene, 2026
  3. Interferon-alpha 2b (IFNα2b) enhances monocyte-derived dendritic cell maturation and Th1-skewed anti-tumor immunity in non-small cell lung cancer
    Molecular Biology Reports, 2026
  4. Brahmi (Bacopa monnieri) plant preparation facilitates to enhance the activities of dendritic cells to control non-small cell lung cancer (NSCLC)
    Journal of Cancer Research and Clinical Oncology, 2026
  5. Epigenetic mechanisms and therapeutic targeting across diverse malignancies
    Epigenomics, 2026

Research Outputs

Patent: Process for isolating glycoprotein from neem leaf and its characterization to define the immunomodulatory and cancer preventive functions of this glycoprotein.

Grants / Consultancy

Independent Research Grant(s): 1. As Principal Investigator (PI): Title of the project: “Wiskott Aldrich Syndrome protein (WASp) mediated epigenetic regulation of T helper (Th)...

Links